Target- |
Mechanism- |
|
Originator Org.- |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
崩漏停颗粒治疗异常子宫出血(月经过多)(血瘀证)有效性和安全性的Ⅱ期临床试验
[Translation] Phase II clinical trial on the efficacy and safety of Benglouting granules in the treatment of abnormal uterine bleeding (menorrhagia) (blood stasis syndrome)
初步评价崩漏停颗粒治疗异常子宫出血(月经过多)(血瘀证)的有效性和安全性,探索合理剂量,为Ⅲ期临床试验设计提供依据。
[Translation] To preliminarily evaluate the efficacy and safety of Benglouting Granules in the treatment of abnormal uterine bleeding (menorrhagia) (blood stasis syndrome), explore the reasonable dosage, and provide a basis for the design of Phase III clinical trials.
100 Clinical Results associated with Shuyang Chenggui Hospital
0 Patents (Medical) associated with Shuyang Chenggui Hospital
100 Deals associated with Shuyang Chenggui Hospital
100 Translational Medicine associated with Shuyang Chenggui Hospital